#TLX

Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging Telix (ASX: TLX, NASDAQ: TLX) announced a research collaboration with University Hospital Essen to join the PROMISE-PET registry and develop AI-based prognostic models using 68Ga-PSMA-11 PET imaging and Telix’s AutoML engine.The registry contains standardized PET readings from >15,000 patients across 50+ institutions since 2018; the project will compare AI predictions with established prognostic nomograms.

2 weeks ago

#TLX Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

www.stocktitan.net/news/TLX/telix-joins-for...

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

2 weeks ago

#TLX #6fe41f47-375f-4ef3-a7d9-abf3bc8bd88e #investing #Health #Care

Origin | Interest | Match

0 0 0 0

US Salvage Autos (ussa.bs247.net)

@ussalvageautos.bsky.social

1 month ago

2020 Acura TLX w/Tech Seller: argocycles.com (90.9% positive feedback) Location: US Condition: Used Price: 7900.00 USD Buy It Now

Ad: For Sale - 2020 Acura TLX w/Tech #Acura #TLX #UsedCars

0 0 0 0

Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch Telix (ASX/NASDAQ: TLX) reported unaudited FY 2025 Group revenue of ~US$804M (A$1.2B), in line with upgraded guidance of US$800–820M, and Q4 2025 revenue of ~US$208M (Q4 YoY +46%). Growth was led by the Precision Medicine business (~US$161M in Q4) supported by the successful U.S. launch of Gozellix after CMS reimbursement effective 1 Oct 2025. Key program and commercial milestones include first patients dosed in multiple therapeutic and imaging trials (ProstACT Part 2, SOLACE, BiPASS, Japan TLX591-Px study), NMPA acceptance of TLX591-Px NDA in China, ~55% national PSMA-PET share in Australia, and a strategic collaboration with Varian to explore combinations with external beam radiation therapy.

1 month ago

#TLX Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

www.stocktitan.net/news/TLX/telix-achieves-...

0 0 0 0

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study Telix (TLX) announced the first U.S. patient has been dosed in BiPASS, a Phase 3 trial evaluating Illuccix and Gozellix 68Ga-PSMA-11 PET agents in the pre-biopsy prostate cancer diagnosis setting. The prospective, open-label study will enroll 250 patients across the U.S. and Australia and is designed to support marketing authorization for 68Ga-PSMA-PET in the pre-biopsy pathway. The trial will assess whether combining MRI with 68Ga-PSMA-11 PET improves diagnostic accuracy, reduces unnecessary biopsies (up to 75% of U.S. biopsies are reportedly negative), and enables better patient stratification and biopsy precision if objectives are met.

1 month ago

#TLX First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

www.stocktitan.net/news/TLX/first-u-s-patie...

0 0 0 0

Investors in Telix Pharmaceuticals Face Class Action Lawsuit Over Misleading Drug Development Statements Hagens Berman warns Telix Pharmaceuticals investors of an impending class action due to alleged misrepresentations regarding prostate cancer treatments and supply chains.

2 months ago

Investors in Telix Pharmaceuticals Face Class Action Lawsuit Over Misleading Drug Development Statements #USA #San_Francisco #Prostate_Cancer #Telix_Pharmaceuticals #TLX

0 0 0 0

Investors of Telix Pharmaceuticals Limited Have Chance to Join Securities Fraud Class Action Shareholders of Telix Pharmaceuticals Limited who incurred losses can take part in a securities fraud class action lawsuit led by The Law Offices of Frank R. Cruz.

2 months ago

Investors of Telix Pharmaceuticals Limited Have Chance to Join Securities Fraud Class Action #USA #Los_Angeles #Securities_Fraud #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix Pharmaceuticals Faces Class Action Over Alleged Drug Progress Misstatements Telix Pharmaceuticals is facing a class action lawsuit for alleged misstatements regarding their prostate cancer drug's progress and supply chain reliability, impacting investor confidence.

2 months ago

Telix Pharmaceuticals Faces Class Action Over Alleged Drug Progress Misstatements #United_States #San_Francisco #Telix_Pharmaceuticals #Hagens_Berman #TLX

0 0 0 0

Howard G. Smith Law Offices Announce Class Action Opportunities for Shareholders of Multiple Companies Investors affected by securities fraud in FUN, TLX, LRN, and PRMB can lead class action lawsuits. Act now to secure your legal rights.

2 months ago

Howard G. Smith Law Offices Announce Class Action Opportunities for Shareholders of Multiple Companies #USA #Bensalem #Howard_G._Smith #fun #TLX

0 0 0 0

Key Timeline for Telix Pharmaceuticals Shareholders Regarding Legal Rights and Class Action Participation Telix Pharmaceuticals investors are urged to contact The Gross Law Firm before January 9, 2026, to explore their rights and options for recovery.

2 months ago

Key Timeline for Telix Pharmaceuticals Shareholders Regarding Legal Rights and Class Action Participation #USA #New_York #Gross_Law_Firm #Telix_Pharmaceuticals #TLX

0 0 0 0

Hagens Berman Urges Telix Investors to Take Action Amid Class Action Deadline Investors in Telix Pharmaceuticals are urged by Hagens Berman to act by January 9 regarding a class action lawsuit tied to SEC subpoenas and FDA concerns.

2 months ago

Hagens Berman Urges Telix Investors to Take Action Amid Class Action Deadline #None #Telix_Pharmaceuticals #Hagens_Berman #TLX

0 0 0 0

Class Action Lawsuit Against Telix Pharmaceuticals: Important Information for Shareholders The Gross Law Firm announces a class action lawsuit against Telix Pharmaceuticals Ltd. Shareholders must act by January 9, 2026, to join.

2 months ago

Class Action Lawsuit Against Telix Pharmaceuticals: Important Information for Shareholders #United_States #New_York #Gross_Law_Firm #Telix_Pharmaceuticals #TLX

0 0 0 0

Class Action Lawsuit Against Telix Pharmaceuticals Ltd. Initiated by Levi & Korsinsky for Investor Recovery A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. by Levi & Korsinsky, seeking recovery for investors affected by alleged fraud. Key details and opportunities for affected investors are outlined.

2 months ago

Class Action Lawsuit Against Telix Pharmaceuticals Ltd. Initiated by Levi & Korsinsky for Investor Recovery #United_States #New_York #Investor_Recovery #Telix_Pharmaceuticals #TLX

0 0 0 0

Current Legal Action Concerning Telix Pharmaceuticals Ltd. Invites Investors to Join the Class Investors of Telix Pharmaceuticals Ltd. affected by alleged securities fraud are encouraged to contact Levi & Korsinsky for potential class action participation.

2 months ago

Current Legal Action Concerning Telix Pharmaceuticals Ltd. Invites Investors to Join the Class #United_States #New_York #Levi_&_Korsinsky #Telix_Pharmaceuticals #TLX

0 0 0 0

Investors of Telix Pharmaceuticals Ltd. Targeted by Class Action Lawsuit Amid Concerns Over Securities Fraud Levi & Korsinsky announces a class action lawsuit against Telix Pharmaceuticals Ltd., raising concerns over alleged securities fraud impacting investors during 2025.

2 months ago

Investors of Telix Pharmaceuticals Ltd. Targeted by Class Action Lawsuit Amid Concerns Over Securities Fraud #USA #New_York #Levi_&_Korsinsky #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix Pharmaceuticals Faces Lawsuit Over Securities Law Violations: Shareholders Informational Update Telix Pharmaceuticals Ltd. is currently facing a lawsuit related to securities law violations. Shareholders are urged to contact The Gross Law Firm to learn about their rights.

2 months ago

Telix Pharmaceuticals Faces Lawsuit Over Securities Law Violations: Shareholders Informational Update #United_States #New_York #Gross_Law_Firm #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix Pharmaceuticals Shareholders Urged to Act in Class Action Lawsuit by The Gross Law Firm The Gross Law Firm has notified shareholders of Telix Pharmaceuticals Ltd. about a class action lawsuit, with key deadlines coming up soon.

3 months ago

Telix Pharmaceuticals Shareholders Urged to Act in Class Action Lawsuit by The Gross Law Firm #United_States #New_York #Gross_Law_Firm #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration Telix (ASX/NASDAQ: TLX) announced a strategic clinical collaboration with Varian, a Siemens Healthineers company, on Dec 10, 2025 to develop integrated theranostics and external beam radiation therapy (EBRT) applications.The initial investigational focus is PSMA-PET imaging for prostate cancer, evaluating Gozellix and Illuccix to help select patients for EBRT, support personalized plans (including Varian Ethos adaptive radiotherapy), and monitor response. The agreement enables both company‑sponsored and investigator‑led clinical studies and is structured as a broad framework for future co‑development across Telix’s PET candidates including Zircaix (TLX250-CDx) and Pixclara (TLX101-CDx).Safety notes in the release highlight image interpretation limitations, radiation exposure risks, and adverse reaction data from studies (960 and 1003 patients) with mostly low rates of nausea, diarrhea, dizziness and fatigue.

3 months ago

#TLX Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

www.stocktitan.net/news/TLX/telix-and-varia...

0 0 0 0

Telix Pharmaceuticals Faces Class Action Lawsuit for Securities Violations: Important Updates for Shareholders Telix Pharmaceuticals Ltd. is being sued for alleged securities law violations. Shareholders are urged to register before the January 9, 2026 deadline.

3 months ago

Telix Pharmaceuticals Faces Class Action Lawsuit for Securities Violations: Important Updates for Shareholders #USA #New_York #securities_lawsuit #Telix_Pharmaceuticals #TLX

0 0 0 0

Opportunity for Telix Pharmaceutical Shareholders to Join Class Action Lawsuit Against Securities Fraud Shareholders of Telix Pharmaceuticals Limited are invited to participate in a securities fraud class action lawsuit. Act now to safeguard your rights.

3 months ago

Opportunity for Telix Pharmaceutical Shareholders to Join Class Action Lawsuit Against Securities Fraud #USA #Bensalem #Howard_Smith_Law #Telix_Pharmaceuticals #TLX

0 0 0 0

ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit {"summary":"","positive":[],"negative":[],"faq":[]}

3 months ago

#TLX ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit

www.stocktitan.net/news/TLX/attention-nasda...

0 0 0 0

Investors in Telix Pharmaceuticals Can Lead Major Securities Fraud Lawsuit Investors in Telix Pharmaceuticals are urged to join a class action lawsuit highlighting alleged securities fraud against the company. Here’s what to know.

3 months ago

Investors in Telix Pharmaceuticals Can Lead Major Securities Fraud Lawsuit #USA #New_York #Rosen_Law_Firm #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix Pharmaceuticals Faces Class Action Lawsuit Over Allegations of Misrepresentation in Cancer Drug Development Telix Pharmaceuticals has come under fire with a class action lawsuit alleging false statements on drug development and supply chain issues. Investors are seeking accountability.

3 months ago

Telix Pharmaceuticals Faces Class Action Lawsuit Over Allegations of Misrepresentation in Cancer Drug Development #United_States #San_Francisco #Securities_Class_Action #Telix_Pharmaceuticals #TLX

0 0 0 0

Investors of Telix Pharmaceuticals Are Advised to Reach Out to The Gross Law Firm by January 2026 The Gross Law Firm urges Telix Pharmaceuticals shareholders to contact them by January 9, 2026, regarding potential claims related to misrepresentation during the class period.

3 months ago

Investors of Telix Pharmaceuticals Are Advised to Reach Out to The Gross Law Firm by January 2026 #USA #New_York #Gross_Law_Firm #Telix_Pharmaceuticals #TLX

0 0 0 0

Investors Facing Significant Losses in Telix Pharmaceuticals Should Contact Robbins LLP for Class Action Details Robbins LLP advises Telix Pharmaceuticals shareholders facing losses due to misleading information about prostate cancer therapies. Class action info available.

3 months ago

Investors Facing Significant Losses in Telix Pharmaceuticals Should Contact Robbins LLP for Class Action Details #United_States #San_Diego #Robbins_LLP #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix Pharmaceuticals Faces Securities Class Action Over False Statements on Cancer Drug Development and Supply Chain Issues Telix Pharmaceuticals is under legal scrutiny due to allegations of misleading investors regarding its prostate cancer drugs and supply chain stability.

3 months ago

Telix Pharmaceuticals Faces Securities Class Action Over False Statements on Cancer Drug Development and Supply Chain Issues #United_States #San_Francisco #Prostate_Cancer #Telix_Pharmaceuticals #TLX

0 0 0 0

Telix Pharmaceuticals Faces Investor Lawsuit Over Alleged Misstatements in Cancer Drug Development Telix Pharmaceuticals Ltd. is now facing a securities class action lawsuit after alleged misstatements regarding its prostate cancer drug progress and supply chain reliability.

3 months ago

Telix Pharmaceuticals Faces Investor Lawsuit Over Alleged Misstatements in Cancer Drug Development #None #securities_lawsuit #Telix_Pharmaceuticals #TLX

0 0 0 0